Groowe Groowe / Newsroom / HRMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

HRMY News

Harmony Biosciences Holdings, Inc. Common Stock

RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry

prnewswire.com
BIIB REGN GILD BTE BROS BFLY BCTX BCRX BTAI ALRS CAPR CRIS CYCN EXAS FATE GNTX HRMY INCY IONS KODK LAKE LULU MRNA NBIX NTRA OCGN ORGN PGEN PLRX RARE RGNX RXRX SAVA SGMO SNOW SRPT STEM TGTX TLSA TXG VRTX ZETA

Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026

globenewswire.com
HRMY

Form 8-K

sec.gov
HRMY

Form 8-K

sec.gov
HRMY

Form 8-K

sec.gov
HRMY

Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities

businesswire.com
HRMY

Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

businesswire.com
HRMY

Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting

businesswire.com
HRMY

Form 8-K

sec.gov
HRMY

Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer

businesswire.com
HRMY